[ad_1]
The news that has been circulating over the past two days about gene therapy is the first of its kind in the treatment of cancer, which has provoked many controversies among the public, especially cancer patients, which has led the UAE and Saudi authorities to clarify this problem. In response to inquiries regarding the new anti-cancer drug, called "Vitracafe".
He is also known as "Lauterkteinp". VITRAKFI is an effective drug in a very limited number of types of cancerous tumors carrying genetic mutations and should not exceed 1% in some species, experts said. The experts pointed out that "Vitracafe" is not effective for cancer patients at the early stages, nor the second or third, but is dedicated to cancer patients at the fourth stage, the stage of the spread of the cancerous tumor in the body.
The experts pointed out that the number of patients who can benefit from this drug is very limited due to the lack of these mutations. In addition, this response rate is also achieved with conventional cancer treatments, chemotherapy, radiotherapy and surgical procedures.
The Ministry of Health issued a statement Sunday evening of the Saudi press agency SPA, which refuted "the accuracy" of media and communication platforms on Vitrakvi and its treatment against cancer. Vitracave does not replace the three traditional cancer treatments, the ministry said.
It does not completely treat the disease either, but only aims to control the spread of the cancerous tumor in the body as long as possible. The ministry said the drug did not completely treat the original cancer, as recently mentioned in the media, but aimed to control the growth of cancer and its spread for as long as possible, and did not replace surgical treatment, chemotherapy and radiotherapy.
Read also:
The world's first cancer treatment, its price is $ 393,600
Source link
